Newsletter | June 26, 2026

06.26.26 -- Reimagining In Vivo Gene Editing Through Base Editing And Targeted Delivery

SPONSOR

Webinar: A Closer Look at How Single Use Consumables Drive Cost per Therapy

Single-use consumables play a critical role in cell and gene therapy manufacturing, influencing cost per therapy, scalability, and operational risk. Join Invetech to explore how early consumable design decisions impact development through commercialization, where consumables add value, and how to identify cost and risk signals sooner. Learn strategies to support efficient scale-up, validation, and long-term manufacturing success. Click here to learn more.

FOCUS ON SUPPLY CHAIN

9 Logistics And Distribution Recommendations For CGTs

Cell and gene therapy commercialization requires tailored logistics strategies. Explore nine recommendations covering site readiness, reimbursement gaps, packaging, testing, and coordination.

What You Need To Know About Fluoropolymer Bag Cold Chain Durability

Drug manufacturers seek packaging that maintains integrity during processing and freezing, scales up to larger volumes easily, and remains robust throughout the temperature-controlled supply chain.

FOCUS ON CLINICAL TRIALS

Reimagining In Vivo Gene Editing Through Base Editing And Targeted Delivery With Beam Therapeutics' Gopi Shanker, Ph.D.

In episode 2 of this four-part in vivo-focused special series of Cell & Gene: The Podcast, Host Erin Harris sits down with Gopi Shanker, Ph.D., Chief Scientific Officer at Beam Therapeutics, for an in-depth conversation on the rapidly evolving landscape of in vivo gene editing and precision genetic medicines.

FOCUS ON CLINICAL TRIALS

Overcome Data Challenges With Real-Time Workflows And Analytics

See how clinical teams can overcome data access and analysis challenges with real-time workflows, traceable decisions, and flexible analytics to accelerate insights and improve collaboration.

Finding The Solution(s) That Meet The Needs Of Patients, Sites, And Sponsors

Poor enrollment and retention often stem from patient burden and limited site access. Learn how leveraging diverse site networks and remote support can transform the clinical trial experience.

Navigating Biases In Clinical Trial Vendor Selection

Biases, often hidden, can distort vendor selection decisions. Recognizing and addressing them across individuals and teams leads to more objective, aligned, and successful clinical trial outcomes.

CLINICAL TRIALS SOLUTIONS

Data-Driven Strategies For Rare/Ultra-Rare Disease Therapy Development - Veristat, Inc.

Clinical Trial Management System (CTMS) Interface - McCreadie Group

Connect With Cell & Gene: